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SIR — As you point out in your Editorial (Nature 460, 933; 2009) on the distribution of human 
cell lines, withholding scientific material from the broader research community contravenes 
the basic norms of science. We do not believe, however, that standard international consent 
guidelines for donors are the solution to this problem and suggest that these should instead be 
devised on a local scale in collaboration with ethics committees to facilitate tissue distribution. 
 
Far from research being “hindered by restrictions from donors” as you suggest, people are 
generally willing to donate tissue for research, and even to give open-ended consent to 
unspecified future applications. This willingness is underpinned by donors’ faith in medical 
research and in their right to protection and confidentiality; the assumption is that their tissue 
will be used only for ‘ethical’ research. But problems can arise, for example over whether 
consent covers the proposed usage (at present there are many different models of consent, 
ranging from specific to general) and when and how tissue should be discarded (K. Aalto-Setälä 
et al. PLoS Biol. 7, e1000042; 2009). 
 
The answers may not always be obvious, and ethics committees (in collaboration with donors 
or their representatives) need to take into account the kind of tissue involved as well as the 
demographics and potential vulnerability of the donor or donor community, to judge the 
acceptability of the research proposal. 
 
None of this precludes distribution of tissue in the name of scientific progress, nor should it if 
the wishes of donors are to be respected. However, it does challenge any unqualified 
presumption among researchers about access to human material; it also calls into question the 
ethical acceptability of using internationally standardized consent forms, as recommended in 
your Editorial. Rather, we would argue for international standards to ensure that tissue 
distribution is not thwarted by ethics committees, accompanied by a plurality of local 
approaches to obtaining consent. 
 
This strategy would address the problems you outline, while demonstrating respect for moral 
decisions made by individuals and groups and preserving donors’ trust in biological medicine. 
